What is a COVID-19 vaccine ‘breakthrough’ case?
What is a COVID-19 vaccine “breakthrough” case?
It’s when a fully vaccinated person gets infected with the coronavirus. A small number of such cases are expected, and health officials say they’re not a cause for alarm.
COVID-19 vaccines work by teaching the body to recognize the virus. So if you’re exposed to it after vaccination, your immune system should be ready to spring into action and fight it.
In studies, the two-dose COVID-19 vaccines by Pfizer and Moderna were found to prevent illness around 95% of the time. The one-shot Johnson & Johnson shot did so 72% of the time, though direct comparisons are difficult since the vaccines were tested under different circumstances.
While reports of fully vaccinated people occasionally getting the coronavirus may sound alarming, the shots dramatically reduce severe disease and death.
Either way, while the vaccines are very good at protecting us from the virus, it’s still possible to get infected and perhaps develop symptoms.
If you do end up getting sick despite vaccination, experts say the shots are very good at reducing the severity of the illness — and that’s the main reason to get vaccinated.
Most people with breakthrough infections experience mild illness, said Dr. William Moss, a vaccine expert at the Johns Hopkins Bloomberg School of Public Health.
In the U.S., people who weren’t vaccinated make up nearly all hospitalizations and deaths from COVID-19.
It’s difficult to determine why any particular breakthrough case happens. How much of the virus someone is exposed to could be a factor, Moss said. Our individual immune systems also affect how well we respond to the shots. Some people, for example, have health conditions or take medications that could make their immune systems less responsive to the vaccines.
A new CDC report on “breakthrough” infections in people who have been vaccinated against COVID-19 finds that just 2% of such cases result in death.
People might also have been exposed to the virus before the shots took full effect. Though it’s less likely, they may have received a dose that was improperly stored or administered, Moss said.
The Centers for Disease Control and Prevention notes variants could be factors in some breakthrough cases, though evidence so far indicates the vaccines used in the U.S. are protective against them.
Health officials are also watching for signs that breakthrough cases are rising, which could signal that protection from the vaccines is fading and boosters are needed.
